Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia

Journal of Oral Pathology and Medicine

Volumn 43, Issue 3, 2014, Pages 211-216

  Brito, João A R ^a   Gomes, Carolina C ^a   Guimarães, André L S ^b   Campos, Kelma ^a   Gomez, Ricardo S ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

Author keywords

Dysplasia; MicroRNA; Oral cancer; Oral leukoplakia

Indexed keywords

MICRORNA; MICRORNA 181B; MICRORNA 21; MICRORNA 345; UNCLASSIFIED DRUG; MIRN181 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; MIRN345 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; CYTOPLASM; DYSPLASIA; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MALE; MIDDLE AGED; MITOSIS; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VERY ELDERLY; CHEMISTRY; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; MOUTH TUMOR; NUCLEOLUS; PATHOLOGY; PRECANCER; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEOLUS; CELL NUCLEUS; CYTOPLASM; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOPLAKIA, ORAL; MALE; MICRORNAS; MIDDLE AGED; MITOSIS; MOUTH MUCOSA; MOUTH NEOPLASMS; PILOT PROJECTS; PRECANCEROUS CONDITIONS;

EID: 84896319841     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12112     Document Type: Article

References (26)

1. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol 2001; 194: 294-7.
2. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med 2008; 37: 63-9.
3. Pindborg JJ, Reibel J, Holmstrup P. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ and initial carcinoma. J Oral Pathol 1985; 14: 698-708.
4. Tilakaratne WM, Sherriff M, Morgan PR, Odell EW. Grading oral epithelial dysplasia: analysis of individual features. J Oral Pathol Med 2011; 40: 533-40.
5. Pindborg JJ, Daftary DK, Mehta FS. A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol 1977; 43: 383-90.
6. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37: 127-33.
7. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med 2008; 37: 1-10.
8. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007; 36: 575-80.
9. Speight PM. Update on oral epithelial dysplasia and progression to cancer. Head Neck Pathol 2007; 1: 61-6.
10. Cervigne NK, Reis PP, Machado J, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 2009; 18: 4818-29.
11. Tabor MP, Braakhuis BJ, van der Wal JE, et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol 2003; 199: 354-60.
12. Yang CC, Hung PS, Wang PW, et al. miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med 2011; 40: 397-404.
13. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5.
14. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12.
15. Lind PO. Malignant transformation in oral leukoplakia. Scand J Dent Res 1987; 95: 449-55.
16. Barnes L, Everson JW, Reichart P, Sdransky D. WHO - World Health Organization classification of tumours, pathology and genetics of head and neck tumous. Lyon: IARCPress, 2005.
17. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33: 1-9.
18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
19. Liu X, Chen Z, Yu J, Xia J, Zhou X. MicroRNA profiling and head and neck cancer. Comp Funct Genomics 2009; 2009: 1-12.
20. Gomes CC, Gomez RS. MicroRNA and oral cancer: future perspectives. Oral Oncol 2008; 44: 910-4.
21. Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 2010; 411: 846-52.
22. Qi L, Bart J, Tan LP, et al. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer 2009; 9: 163-70.
23. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008; 18: 350-9.
24. Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012; 13: 283-96.
25. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-58.
26. Tang JT, Wang JL, Du W, et al. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis 2011; 32: 1207-15.